Literature DB >> 16843524

Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag.

Marina V Backer1, Vimal Patel, Brian T Jehning, Kevin P Claffey, Joseph M Backer.   

Abstract

Developing tissue engineering scaffolds with immobilized growth factors requires facile and reliable methods for the covalent attachment of functionally active proteins. We describe here a new approach to immobilize recombinant proteins based on expression of the protein of interest with a 15-aa long fusion tag (Cys-tag), which avails a free sulfhydryl group for site-specific conjugation. To validate this approach, we conjugated a single-chain vascular endothelial growth factor expressed with an N-terminal Cys-tag (scVEGF) to fibronectin (FN) using a common thiol-directed bi-functional cross-linking agent. We found that the FN-scVEGF conjugate retains VEGF activity similar to that of free scVEGF when used as a soluble ligand. Cells expressing VEGF receptor VEGFR-2 grown on plates coated with FN-scVEGF displayed morphological phenotypes similar to those observed for cells grown on FN in the presence of equivalent amounts of free scVEGF. In addition, 293/KDR cell growth stimulation was observed in the same concentration range with either immobilized or free scVEGF. The effects of immobilized scVEGF, and soluble scVEGF were blocked by NVP-AAD777-NX, a VEGF receptor tyrosine kinase inhibitor. These data indicate that site-specific immobilization via Cys-tag provides a facile and reliable method for permanent deposition of functionally active growth factors on synthetic or protein scaffolds with applications for advanced tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16843524     DOI: 10.1016/j.biomaterials.2006.06.025

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  22 in total

1.  scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis.

Authors:  Christopher R Anderson; Joshua J Rychak; Marina Backer; Joseph Backer; Klaus Ley; Alexander L Klibanov
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

2.  Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis.

Authors:  H N Ashiqur Rahman; Hao Wu; Yunzhou Dong; Satish Pasula; Aiyun Wen; Ye Sun; Megan L Brophy; Kandice L Tessneer; Xiaofeng Cai; John McManus; Baojun Chang; Sukyoung Kwak; Negar S Rahman; Wenjia Xu; Conrad Fernandes; John Michael Mcdaniel; Lijun Xia; Lois Smith; R Sathish Srinivasan; Hong Chen
Journal:  Circ Res       Date:  2016-02-15       Impact factor: 17.367

3.  Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.

Authors:  Jan-Philip Meyer; Kimberly J Edwards; Paul Kozlowski; Marina V Backer; Joseph M Backer; Jason S Lewis
Journal:  J Nucl Med       Date:  2016-07-07       Impact factor: 10.057

4.  Matrix-Bound VEGF Mimetic Peptides: Design and Endothelial Cell Activation in Collagen Scaffolds.

Authors:  Tania R Chan; Patrick J Stahl; S Michael Yu
Journal:  Adv Funct Mater       Date:  2011-11-22       Impact factor: 18.808

Review 5.  Complexity in biomaterials for tissue engineering.

Authors:  Elsie S Place; Nicholas D Evans; Molly M Stevens
Journal:  Nat Mater       Date:  2009-06       Impact factor: 43.841

Review 6.  Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials.

Authors:  James J Moon; Jennifer L West
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

Review 7.  Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review.

Authors:  Marwa Tallawi; Elisabetta Rosellini; Niccoletta Barbani; Maria Grazia Cascone; Ranjana Rai; Guillaume Saint-Pierre; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2015-07-06       Impact factor: 4.118

Review 8.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

Review 9.  'In vivo' optical approaches to angiogenesis imaging.

Authors:  T J A Snoeks; C W G M Löwik; E L Kaijzel
Journal:  Angiogenesis       Date:  2010-05-08       Impact factor: 9.596

10.  Poly (lactic-co-glycolic acid) as a controlled release delivery device.

Authors:  Tee Yong Lim; Chye Khoon Poh; W Wang
Journal:  J Mater Sci Mater Med       Date:  2009-03-13       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.